Ambev
ABEV
277 hedge funds and large institutions have $3.11B invested in Ambev in 2020 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 88 increasing their positions, 101 reducing their positions, and 60 closing their positions.
85% more call options, than puts
Call options by funds: $289K | Put options by funds: $156K
0.83% more ownership
Funds ownership: 7.78% → 8.61% (+0.83%)
9% less funds holding
Funds holding: 304 → 277 (-27)
13% less repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 101
38% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 60
45% less capital invested
Capital invested by funds: $5.7B → $3.11B (-$2.59B)
57% less funds holding in top 10
Funds holding in top 10: 7 → 3 (-4)
Top Buyers
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$169M |
| 2 |
VAM
Vontobel Asset Management
New York
|
-$157M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$115M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$90.9M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
-$89.9M |
ABEV Hedge Fund Activity: Q1 2020 in Review
277 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Ambev (ABEV) for Q1 2020, worth a combined $3.11B — down 45% from $5.7B a quarter earlier.
Sellers outnumbered buyers: 60 funds closed out of ABEV and 37 opened new positions — a net loss of 23 holders — while 101 trimmed existing stakes and 88 added.
The largest buyer was First Eagle Investment Management, opening a new position worth an estimated $597M. The largest seller was JP Morgan Chase, cutting an estimated $169M.
- 277 institutional investors held Ambev (ABEV) as of Q1 2020, down from 304 in Q4 2019.
- Funds reported $3.11B of Ambev stock for Q1 2020, down 45% quarter-over-quarter.
- 37 funds opened new Ambev positions in Q1 2020 and 60 closed out, a net change of -23 holders.
- The largest Ambev buyer in Q1 2020 was First Eagle Investment Management, an estimated $597M added.
- The largest Ambev seller in Q1 2020 was JP Morgan Chase, an estimated $169M sold.
Based on aggregated 13F filings for Q1 2020.